Literature DB >> 9401776

Binding and effects of KATP channel openers in the vascular smooth muscle cell line, A10.

U Russ1, F Metzger, E Kickenweiz, A Hambrock, P Krippeit-Drews, U Quast.   

Abstract

1. The ATP-sensitive K+ channel (KATP channel) in A10 cells, a cell line derived from rat thoracic aorta, was characterized by binding studies with the tritiated KATP channel opener, [3H]-P1075, and by electrophysiological techniques. 2. Saturation binding experiments gave a KD value of 9.2 +/- 5.2 nM and a binding capacity (BMax) of 140 +/- 40 fmol mg-1 protein for [3H]-P1075 binding to A10 cells; from the BMax value a density of binding sites of 5-10 per microns2 plasmalemma was estimated. 3. KATP channel modulators such as the openers P1075, pinacidil, levcromakalim and minoxidil sulphate and the blocker glibenclamide inhibited [3H]-P1075 binding. The extent of inhibition at saturation depended on the compound, levcromakalim inhibiting specific [3H]-P1075 binding by 85%, minoxidil sulphate and glibenclamide by 70%. The inhibition constants were similar to those determined in strips of rat aorta. 4. Resting membrane potential, recorded with microelectrodes, was -51 +/- 1 mV. P1075 and levcromakalim produced a concentration-dependent hyperpolarization by up to -25 mV with EC50 values of 170 +/- 40 nM and 870 +/- 190 nM, respectively. The hyperpolarization induced by levcromakalim (3 microM) was completely reversed by glibenclamide with an IC50 value of 86 +/- 17 nM. 5. Voltage clamp experiments were performed in the whole cell configuration under a physiological K+ gradient. Levcromakalim (10 microM) induced a current which reversed around -80 mV; the current-voltage relationship showed considerable outward rectification. Glibenclamide (3 microM) abolished the effect of levcromakalim. 6. Analysis of the noise of the levcromakalim (10 microM)-induced current at -40 and -20 mV yielded estimates of the channel density, the single channel conductance and the probability of the channel to be open of 0.14 micron-2, 8.8 pS and 0.39, respectively. 7. The experiments showed that A10 cells are endowed with functional KATP channels which resemble those in vascular tissue; hence, these cells provide an easily accessible source of channels for biochemical and pharmacological studies. The density of binding sites for [3H]-P1075 was estimated to be one order of magnitude higher than the density of functional KATP channels; assuming a plasmalemmal localization of the binding sites this suggests a large receptor reserve for the openers in A10 cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9401776      PMCID: PMC1565060          DOI: 10.1038/sj.bjp.0701514

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

Review 1.  Measuring and evaluating the role of ATP-sensitive K+ channels in cardiac muscle.

Authors:  Eirini Kefaloyianni; Li Bao; Michael J Rindler; Miyoun Hong; Tejaskumar Patel; Eylem Taskin; William A Coetzee
Journal:  J Mol Cell Cardiol       Date:  2012-01-03       Impact factor: 5.000

2.  Pharmacological evidence for a KATP channel in renin-secreting cells from rat kidney.

Authors:  U Russ; U Rauch; U Quast
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

3.  Cardiomyocyte sulfonylurea receptor 2-KATP channel mediates cardioprotection and ST segment elevation.

Authors:  Douglas A Stoller; John P Fahrenbach; Karel Chalupsky; Bi-Hua Tan; Nitin Aggarwal; Jamie Metcalfe; Michele Hadhazy; Nian-Qing Shi; Jonathan C Makielski; Elizabeth M McNally
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-23       Impact factor: 4.733

4.  A mechanism for ATP-sensitive potassium channel diversity: Functional coassembly of two pore-forming subunits.

Authors:  Y Cui; J P Giblin; L H Clapp; A Tinker
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

5.  Nitric Oxide is Necessary for Diazoxide Protection Against Ischemic Injury in Skeletal Muscle.

Authors:  Hossein Farahini; Marjan Ajami; Jalaledin Mirzay Razaz; Nahid Azad; Mansooreh Soleimani; Seyyed Abdulmajid Ayatollahi; Nahid Abotaleb; Habibolah Peyrovi; Hamidreza Pazoki-Toroudi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.